Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients

DSpace/Manakin Repository

Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients

Citable link to this page

 

 
Title: Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients
Author: Tirumani, Sree Harsha; Deaver, Pamela; Shinagare, Atul B.; Tirumani, Harika; Hornick, Jason L.; George, Suzanne; Ramaiya, Nikhil H.

Note: Order does not necessarily reflect citation order of authors.

Citation: Tirumani, Sree Harsha, Pamela Deaver, Atul B. Shinagare, Harika Tirumani, Jason L. Hornick, Suzanne George, and Nikhil H. Ramaiya. 2014. “Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.” Journal of Gynecologic Oncology 25 (4): 306-312. doi:10.3802/jgo.2014.25.4.306. http://dx.doi.org/10.3802/jgo.2014.25.4.306.
Full Text & Related Files:
Abstract: Objective: To describe metastatic pattern of uterine leiomyosarcomas (ULMS) and correlate it with clinical and histopathologic parameters. Methods: We included 113 women (mean age, 53 years; range, 29 to 72 years) with histopathology-confirmed ULMS from 2000 to 2012. Distribution of metastases was noted from imaging by two radiologists in consensus. Predictors of development of metastases were analyzed with univariate and multivariate analysis. Impact of various clinical and histopathologic parameters on survival was compared using Log-rank test and Cox proportional hazard regression model. Results: Distant metastases were seen in 81.4% (92/113) of the patients after median interval of 7 months (interquartile range, 1 to 21). Lung was most common site of metastases (74%) followed by peritoneum (41%), bones (33%), and liver (27%). Local tumor recurrence was noted in 57 patients (50%), 51 of whom had distant metastases. Statistically significant correlation was noted between local recurrence and peritoneal metastases (p<0.001) and between lung and other common sites of hematogeneous metastases (p<0.05). Age, serosal involvement, local recurrence, and the International Federation of Gynecology and Obstetrics (FIGO) stage were predictive factors for metastases. At the time of reporting, 65% (74/113) of the patients have died; median survival was 45 months. Stage, local recurrence, and age were poor prognostic factors. Conclusion: ULMS metastasizes most frequently to lung, peritoneum, bone, and liver. Local recurrence was associated with peritoneal spread and lung metastases with other sites of hematogeneous metastases. Age, FIGO stage and local recurrence predicted metastatic disease and advanced stage, older age and local recurrence predicted poor outcome.
Published Version: doi:10.3802/jgo.2014.25.4.306
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195301/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347398
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters